The code structure of the p53 DNA-binding domain and the prognosis of breast cancer patients

Bioinformatics. 2013 Nov 15;29(22):2822-5. doi: 10.1093/bioinformatics/btt497. Epub 2013 Aug 27.

Abstract

Motivation: The tumor-suppressor gene TP53 mutations are diverse in the central region encoding the DNA-binding domain. It has not been clear whether the prognostic significance for survival in breast cancer patients is the same for all types of mutations. Are there specific types of mutations carrying a worse prognosis? To understand the correlation between the mutations in the gene encoding the DNA-binding domain and the prognosis of breast cancer, we studied the code structure of the DNA-binding domain of breast cancer patients by using various artificial codes in information transmission.

Results: We indicated that the prognostic significance of all types of mutations in the DNA-binding domain is not the same, and that the DNA-binding domain having a certain code structure is important for estimating the prognosis of breast cancer patients.

Contact: keiko@is.noda.tus.ac.jp or hara@is.noda.tus.ac.jp.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / mortality*
  • Female
  • Genes, p53*
  • Humans
  • Kaplan-Meier Estimate
  • Mutation*
  • Prognosis
  • Protein Structure, Tertiary / genetics
  • Tumor Suppressor Protein p53 / chemistry
  • Tumor Suppressor Protein p53 / genetics

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53